Cargando…

HIV-1 Coinfection Profoundly Alters Intrahepatic Chemokine but Not Inflammatory Cytokine Profiles in HCV-Infected Subjects

The pathogenesis of accelerated liver damage in subjects coinfected with hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) remains largely unknown. Recent studies suggest that ongoing chronic liver inflammation is responsible for the liver injury in HCV-infected patients. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Sishun, Ghabril, Marwan, Amet, Tohti, Hu, Ningjie, Byrd, Daniel, Yang, Kai, Vuppalanchi, Raj, Saxena, Romil, Desai, Mona, Lan, Jie, Johnson, Raymond, Gupta, Samir, Chalasani, Naga, Yu, Qigui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916319/ https://www.ncbi.nlm.nih.gov/pubmed/24516541 http://dx.doi.org/10.1371/journal.pone.0086964

Ejemplares similares

Direct Effects of HIV-1 Tat on Excitability and Survival of Primary Dorsal Root Ganglion Neurons: Possible Contribution to HIV-1-Associated Pain
por: Chi, Xianxun, et al.
Publicado: (2011)

Association of Neisseria gonorrhoeae Opa(CEA) with Dendritic Cells Suppresses Their Ability to Elicit an HIV-1-Specific T Cell Memory Response
por: Yu, Qigui, et al.
Publicado: (2013)

Serum Hepcidin Levels Are Associated With Obesity but Not Liver Disease
por: Vuppalanchi, Raj, et al.
Publicado: (2013)

Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33(+)CD11b(+)HLA-DR(+) Cells: A Cross-Sectional Study
por: Meng, Zhefeng, et al.
Publicado: (2016)

Treatment of Idiosyncratic Drug-Induced Liver Injury Using Steroids
por: Sundaram, Suneha, et al.
Publicado: (2020)

Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network
por: Ma, Jiayi, et al.
Publicado: (2022)

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
por: Ngwa, Taiwo, et al.
Publicado: (2020)

Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis
por: Orman, Eric S., et al.
Publicado: (2019)

4295 The Impact of Social Determinants of Health on Hepatocellular Carcinoma Outcomes
por: Nephew, Lauren Devore, et al.
Publicado: (2020)

Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury
por: Ghabril, Marwan, et al.
Publicado: (2020)

Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders
por: Desai, Archita P., et al.
Publicado: (2021)

Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States
por: Nephew, Lauren D., et al.
Publicado: (2020)

Sex disparities in waitlisting and liver transplant for acute liver failure
por: Nephew, Lauren D., et al.
Publicado: (2020)

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study
por: Nephew, Lauren D., et al.
Publicado: (2023)

Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018
por: Nephew, Lauren D., et al.
Publicado: (2023)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation
por: Mohamed, Kawthar A., et al.
Publicado: (2022)

Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
por: Soma, Daiki, et al.
Publicado: (2022)

Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease
por: Coppel, Scott, et al.
Publicado: (2020)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Therapeutic issues in HIV/HCV-coinfected patients
por: Sulkowski, M S, et al.
Publicado: (2007)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Evidence for Implementation: HIV/HCV Coinfection and Pregnancy
por: Curtis, Megan Rose, et al.
Publicado: (2023)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist
por: Nephew, Lauren D., et al.
Publicado: (2022)

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
por: Dakhoul, Lara, et al.
Publicado: (2018)

MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis
por: Fricker, Zachary P., et al.
Publicado: (2020)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation
por: Steiner-Temnykh, Lindsey, et al.
Publicado: (2020)

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

HCV-HIV Chronic Coinfection Prevalence in Amazon Region
por: Lobo, Marcio Nahum, et al.
Publicado: (2022)

Dynamic Alterations to Hepatic MicroRNA-29a in Response to Long-Term High-Fat Diet and EtOH Feeding
por: Liang, Tiebing, et al.
Publicado: (2023)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation
por: McCabe, Marshall, et al.
Publicado: (2021)

Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rjvds58nmcrbkh7ds0jcd8gb3f